Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Application of Hi-C sequencing to detect oncogene rearrangements for diagnosis and treatment of large B-cell lymphoma.

Blood advances·2026

Same author

The long noncoding RNA lnc13 restrains inflammatory responses to maintain oral tolerance to gluten.

Nature immunology·2026

Same author

The normal human lymph node cell classification and landscape defined by high-dimensional spatial proteomics.

PloS one·2026

Same author

Double potential gradient analysis for critical isthmus detection in scar-related atrial tachycardia.

Heart rhythm·2026

Same author

Automated Detection of Macro-Reentrant Atrial Tachycardia Circuits Using LAT-Derived Graph Networks.

medRxiv : the preprint server for health sciences·2026

Same author

Sinus Rhythm Parameters in the Infarct Border Zone Are Useful to Assess Reentrant Ventricular Tachycardia Inducibility.

Journal of cardiovascular electrophysiology·2026

Search research articles

Related Experiment Video

Updated: Jan 14, 2026

Artificial Intelligence Approaches to Assessing Primary Cilia

Artificial Intelligence Approaches to Assessing Primary Cilia

Published on: May 1, 2021

Emerging Technology: Artificial Intelligence and Celiac Disease.

Edward J Ciaccio¹, Govind Bhagat², Peter H Green¹

¹Department of Medicine - Celiac Disease Center, Columbia University Vagelos College of Physicians and Surgeons, New York, NY, USA.

Gastrointestinal Endoscopy Clinics of North America

|October 17, 2025

Summary

This summary is machine-generated.

Artificial intelligence (AI) aids in early detection of celiac disease by analyzing complex data. AI also accelerates understanding of disease onset, risk factors, and autoimmune comorbidities.

Keywords:

Artificial intelligence Autoimmune disease Celiac disease Deep learning Machine learning

More Related Videos

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

Related Experiment Videos

Last Updated: Jan 14, 2026

Artificial Intelligence Approaches to Assessing Primary Cilia

Artificial Intelligence Approaches to Assessing Primary Cilia

Published on: May 1, 2021

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases

Published on: May 29, 2020

Area of Science:

Immunology
Medical Informatics
Computational Biology

Background:

Celiac disease is a prevalent autoimmune disorder affecting 1-2% globally, triggered by gluten.
Early diagnosis and understanding of celiac disease pathogenesis remain challenging.

Purpose of the Study:

To explore the application of artificial intelligence (AI) in improving celiac disease detection and research.
To leverage machine and deep learning for analyzing diverse celiac disease-related data.

Main Methods:

AI algorithms, including machine and deep learning, were employed.
Analysis encompassed serologic, genetic, histopathologic, and endoscopic imaging data.
AI identified subtle patterns for enhanced diagnostic accuracy.

Main Results:

AI demonstrated potential in enhancing early detection of celiac disease.
AI facilitated accelerated discovery of insights into disease onset and progression.
AI highlighted potential risk factors and comorbidities with other autoimmune conditions.

Conclusions:

AI offers promising solutions for overcoming challenges in celiac disease diagnosis and research.
AI's pattern recognition capabilities can improve diagnostic sensitivity and speed up scientific discovery.
Further integration of AI in celiac disease research is warranted for improved patient outcomes.